Xuan Yi
State Key Laboratory Of Organ Failure Research, Guangdong Provincial Key Laboratory Of Viral Hepatitis Research
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dissecting antibody-mediated natural killer cell effects reveals a cytotoxic CX3CR1+KLRC2-CD16hi subset linked to hepatitis B virus outcomes.
Journal: Clinical and molecular hepatology
Published: August 18, 2025
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: July 04, 2023
IL-21 collaborates with anti-TIGIT to restore NK cell function in chronic HBV infection.
Journal: Journal of medical virology
Published: June 22, 2023
Pre-existing immunity to SARS-CoV-2 associates with strong T cell responses induced by inactivated COVID-19 vaccines.
Journal: Journal of medical virology
Published: December 14, 2022
Differential response of HBV envelope-specific CD4 + T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapy.
Journal: Hepatology (Baltimore, Md.)
Published: May 15, 2022
Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay.
Journal: Journal of leukocyte biology
Published: February 27, 2020
IL-21 receptor signaling is essential for control of hepatocellular carcinoma growth and immunological memory for tumor challenge.
Journal: Oncoimmunology
Published: May 14, 2018
A recombinant adenovirus vector carrying murine interleukin-21 gene controls chronic HBV infection in mice
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: November 29, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026